By Stephanie Lowitt
This spring, New England Stop & Shop customers donated over $760,000 to pediatric cancer research at Dana-Farber through the grocery chain’s annual Help Cure Childhood Cancer campaign. Over the month-long campaign, customers were invited to round up their purchases to the nearest dollar or contribute $1, $3, or $5 at checkout, contributing to the nearly $78 million raised for the Institute since 1991.
“Stop & Shop and its customers have been proud supporters of the Jimmy Fund and Dana-Farber Cancer Institute for more than 30 years. Through initiatives like the register campaign we run at our stores across Massachusetts, Rhode Island, and Connecticut, we’re committed to helping Dana-Farber provide kids with improved treatments and care—and to enable critical research in the search for a cure,” says Stop & Shop’s Executive Vice President, Operations, Dean Wilkinson. “Each year, Jimmy Fund Clinic patients serve as ambassadors for our campaign. It’s the opportunity to work directly with those kids and to celebrate their strength and bravery that makes the campaign so special.”
Ongoing support from the grocery chain has funded the Stop & Shop Pediatric Brain Tumor Clinic at Dana-Farber, a world-renowned destination for children with malignant and nonmalignant brain tumors, as well as the Stop & Shop Family Pediatric Neuro-Oncology Outcomes Clinic (also known as EmPOWER) and the Adolescent and Young Adult Brain Tumor Clinic, which encourage and enable patients and their families to lead the healthiest, most fulfilling lives following brain tumor treatment.
“It’s the opportunity to work directly with those kids and to celebrate their strength and bravery that makes the campaign so special.”Dean Wilkinson, Stop & Shop
“Dana-Farber is proud to have partnered with Stop & Shop for over 30 years,” says Lisa Diller, MD, vice chair of the Department of Pediatric Oncology at Dana-Farber. “Their support has helped us move the needle in pediatric cancer research and care. We look forward to continuing to partner for many years to come as we work together to improve outcomes for pediatric cancer patients and their families.”